BACKGROUND: Current diagnostic criteria for dementia with Lewy bodies (DLB) include indicative and supportive biomarkers, some of which are typically assessed separately using dopamine transporter or perfusion imaging. The gene discussed is SLC6A3; the disease is Lewy body dementia.